These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 9010920)
21. The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled study. Stevens JE; Horowitz M; Deacon CF; Nauck M; Rayner CK; Jones KL Aliment Pharmacol Ther; 2012 Aug; 36(4):379-90. PubMed ID: 22738299 [TBL] [Abstract][Full Text] [Related]
22. The antagonistic metabolite of GLP-1, GLP-1 (9-36)amide, does not influence gastric emptying and hunger sensations in man. Nagell CF; Pedersen JF; Holst JJ Scand J Gastroenterol; 2007 Jan; 42(1):28-33. PubMed ID: 17190759 [TBL] [Abstract][Full Text] [Related]
23. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226 [TBL] [Abstract][Full Text] [Related]
24. The effects of general anaesthesia on antroduodenal motility, gastric pH and gastric emptying in man. Schurizek BA Dan Med Bull; 1991 Aug; 38(4):347-65. PubMed ID: 1914534 [TBL] [Abstract][Full Text] [Related]
25. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans. Dupre J Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434 [TBL] [Abstract][Full Text] [Related]
26. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs. Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625 [TBL] [Abstract][Full Text] [Related]
27. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia. Deane AM; Chapman MJ; Fraser RJ; Summers MJ; Zaknic AV; Storey JP; Jones KL; Rayner CK; Horowitz M Crit Care Med; 2010 May; 38(5):1261-9. PubMed ID: 20228679 [TBL] [Abstract][Full Text] [Related]
28. Monosodium glutamate stimulates secretion of glucagon-like peptide-1 and reduces postprandial glucose after a lipid-containing meal. Hosaka H; Kusano M; Zai H; Kawada A; Kuribayashi S; Shimoyama Y; Nagoshi A; Maeda M; Kawamura O; Mori M Aliment Pharmacol Ther; 2012 Nov; 36(9):895-903. PubMed ID: 22978669 [TBL] [Abstract][Full Text] [Related]
29. Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women. Brennan IM; Feltrin KL; Nair NS; Hausken T; Little TJ; Gentilcore D; Wishart JM; Jones KL; Horowitz M; Feinle-Bisset C Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G602-10. PubMed ID: 19556358 [TBL] [Abstract][Full Text] [Related]
31. Glucagon-like peptide-1 (7-36) amide response to low versus high glycaemic index preloads in overweight subjects with and without type II diabetes mellitus. Milton JE; Sananthanan CS; Patterson M; Ghatei MA; Bloom SR; Frost GS Eur J Clin Nutr; 2007 Dec; 61(12):1364-72. PubMed ID: 17299480 [TBL] [Abstract][Full Text] [Related]
32. Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying. Nicolaus M; Brödl J; Linke R; Woerle HJ; Göke B; Schirra J J Clin Endocrinol Metab; 2011 Jan; 96(1):229-36. PubMed ID: 21047924 [TBL] [Abstract][Full Text] [Related]
34. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses. Little TJ; Pilichiewicz AN; Russo A; Phillips L; Jones KL; Nauck MA; Wishart J; Horowitz M; Feinle-Bisset C J Clin Endocrinol Metab; 2006 May; 91(5):1916-23. PubMed ID: 16492694 [TBL] [Abstract][Full Text] [Related]
35. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation. Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144 [TBL] [Abstract][Full Text] [Related]
36. Effects of gastric emptying on the postprandial ghrelin response. Blom WA; Lluch A; Vinoy S; Stafleu A; van den Berg R; Holst JJ; Kok FJ; Hendriks HF Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E389-95. PubMed ID: 16188911 [TBL] [Abstract][Full Text] [Related]
37. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients. Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123 [TBL] [Abstract][Full Text] [Related]
38. The physiological role of GLP-1 in human: incretin, ileal brake or more? Schirra J; Göke B Regul Pept; 2005 Jun; 128(2):109-15. PubMed ID: 15780430 [TBL] [Abstract][Full Text] [Related]
39. Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects. Steinert RE; Poller B; Castelli MC; Friedman K; Huber AR; Drewe J; Beglinger C Clin Pharmacol Ther; 2009 Dec; 86(6):644-50. PubMed ID: 19727071 [TBL] [Abstract][Full Text] [Related]
40. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. Meier JJ; Gallwitz B; Salmen S; Goetze O; Holst JJ; Schmidt WE; Nauck MA J Clin Endocrinol Metab; 2003 Jun; 88(6):2719-25. PubMed ID: 12788879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]